封面
市场调查报告书
商品编码
1471959

蛋白质体学市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围:按产品和服务、应用、最终用户和地理位置

Proteomics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Service, Application, End User, and Geography

出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

根据我们关于「2030 年蛋白质体学市场预测- COVID-19 影响和全球分析- 按产品和服务、应用程式和最终用户划分」的新研究,该市场预计将从2022 年的270.7 亿美元增长,并预计到2030年达到750.3亿美元;预计2022-2030年复合年增长率为13.6%。市场成长归因于慢性病病例的激增和奈米蛋白质组学的日益突出。不断增长的技术进步和研发支出可能为蛋白质组学市场提供成长机会。然而,仪器成本高昂和技术人员缺乏阻碍了蛋白质体学市场的成长。

蛋白质体学,即蛋白质的详细分析,已成为研究药物开发、治疗、预后和疾病特征的重要领域。蛋白质体学技术有助于传染性和非传染性疾病的检测和治疗。透过使用奈米技术作为技术平台,目前的蛋白质体学方法变得更加可靠、生物相容性、特异性和可重复性。使用奈米材料透过蛋白质操作来提高蛋白质组技术的质量,大大评估了传统蛋白质组技术的缺点。在製药领域,蛋白质体学研究药物作用或毒性机制。它们也广泛用于识别和确认生物标誌物的有效性。

到2022年,北美将占据全球蛋白质体市场的主要份额。推动该地区市场成长的关键因素是对基于结构的药物设计开发的投资不断增加、对资料可重复性的高品质研究工具的需求、组学研究的成长等。主要区域公司之间的伙伴关係和合作也有助于该地区的市场扩张。例如,Thermo Fisher Scientific Inc. 和 Symphogen 合作开发了经过验证的平台流程,用于优化复杂治疗性蛋白质的表征和品质监控。此外,蛋白质体学研究在美国等国家正处于鼎盛时期。

不断增长的技术进步和研发支出为未来提供市场机会

蛋白质组学行业的製造商致力于提供用于疾病诊断的新方法和设备。安捷伦科技公司等公司已经认识到使用技术外包策略专注于开发蛋白质分析产品的优势。透过使用蛋白质体学技术,可以实现基于蛋白质的诊断的绝对定量。关键的蛋白质体学服务和其他技术,包括微阵列、X射线晶体学、光谱技术、色谱、电泳和表面等离子体共振系统,构成了蛋白质组学市场的基础。

蛋白质体学研究和开发的投资不断增加正在促进市场成长。美国国立卫生研究院 (NIH) 拨款 370 亿美元用于生物医学研究。这笔资金将有助于研究疾病发展的基本机制,识别表明疾病存在的生物标记物,或识别导致疾病的基因或蛋白质。诺和诺德基金会向哥本哈根大学提供高达 150 万美元的资助,用于建造质谱设施,这是蛋白质研究的重要一步。 COVID-19 爆发后,市场迅速成长。

关键参与者对于改善发展中国家人民获得优质医疗保健和药品的机会至关重要,这也扩大了发展中国家的经济前景,他们也努力透过创造更多就业机会、进行大量投资、影响公共政策和提供培训来增加经济机会。製药业对发展中国家经济机会的成长有重大影响。近年来,製药公司取得了优异的财务表现。例如,赛默飞世尔科技公司 (Thermo Fisher Scientific, Inc.) 去年公布了创纪录的利润,预计未来业绩会更好。随着多家生物製药公司逐渐成为主要参与者并且正在进行各种研发活动,该市场将继续蓬勃发展,从而为全球市场提供成长机会。

基于产品和服务的见解

根据产品和服务,蛋白质体学市场分为仪器技术、试剂和耗材以及软体和服务。试剂和耗材细分市场在 2022 年占据最大的市场份额,并可能在 2022 年至 2030 年期间实现最高的复合年增长率,达到 14.1%。

试剂和试剂盒、耗材和试纸条越来越多地用于研究大学、研究机构和其他领域的各种生物材料的研究。政府在蛋白质体学和基因组学领域的措施正在推动疾病诊断的研究活动。 3D 电泳蛋白质分析仪等先进仪器的技术进步提高了生物研究的速度、效率和生产力,也推动了对试剂和耗材的需求。这些因素促进了该领域蛋白质体学市场规模的不断增长。

基于应用程式的见解

该市场根据应用分为临床诊断、药物发现和开发等。临床诊断领域在 2022 年占据最大的蛋白质体学市场份额。

基于最终用户的见解

根据最终用户,市场分为製药和生物技术公司、研究和临床实验室、医院等。製药和生物技术公司领域在 2022 年占据最大的蛋白质组市场份额。

领先企业正在实施扩张、合作、推出新产品和获取新客户群等策略,以挖掘现有的商机。

2022 年 1 月,Seer, Inc. 宣布推出卓越中心计画并商业发布 Proteograph 产品套件。 Proteograph 产品套件提供公正、无与伦比的蛋白质体存取。该方法使用独特设计的奈米粒子来生产突破性产品,从而实现快速、彻底和公正的大规模蛋白质体学。

In February 2021, Agilent Technologies Inc. launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit, designed for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or电浆.

2021 年 2 月,Pochon Scientific, LLC 购买了一台新型 Thermo Orbitrap Exploris 240 质谱仪,该质谱仪具有 BioPharma 选项和 FAIMS Pro 介面。它是一款多功能、新一代高分辨率质谱仪,可为蛋白质组学、代谢组学和生物製药表征提供卓越的性能。

美国食品药物管理局、疾病管制与预防中心 (CDC) 和全球疾病负担研究是准备蛋白质体学市场报告时参考的主要和次要来源。

目录

第 1 章:简介

第 2 章:要点

第 3 章:研究方法

第 4 章:蛋白质体学市场格局

  • 概述
  • 害虫分析
    • 北美 - 害虫分析
    • 欧洲 - 害虫分析
    • 亚太地区 - 害虫分析
    • 中东和非洲 - 害虫分析
    • 南美洲和中美洲 - 害虫分析
  • 专家意见

第 5 章:蛋白质体学市场 - 主要市场动态

  • 主要市场驱动因素
  • 主要市场限制
  • 主要市场机会
  • 未来的趋势
  • 驾驶员和约束的影响分析

第 6 章:蛋白质体学市场 - 全球市场分析

  • 蛋白质体学 - 全球市场概览
  • 蛋白质体学 - 全球市场与 2028 年预测
  • 市场定位

第 7 章:蛋白质体学市场 - 收入与 2028 年预测 - 工具

  • 概述
  • 仪器仪表市场预测与分析
  • 光谱学
    • 概述
    • 光谱市场预测与分析
    • 质谱市场
      • 概述
      • 质谱市场预测与分析
    • 核磁共振波谱市场
      • 概述
      • 核磁共振波谱市场预测与分析
    • 圆二色性 (CD) 光谱市场
      • 概述
      • 圆二色性 (CD) 光谱市场预测与分析
  • 色谱法
    • 概述
    • 色谱市场预测与分析
    • 高效液相层析市场
      • 概述
      • HPLC市场预测与分析
    • 离子色谱市场
      • 概述
      • 离子色谱市场预测与分析
    • 离子色谱市场
      • 概述
      • 离子色谱市场预测与分析
    • 超临界流体层析市场
      • 概述
      • 超临界流体色谱市场预测与分析
  • 电泳
    • 概述
    • 电泳市场预测与分析
    • 凝胶电泳市场
      • 概述
      • 凝胶电泳市场预测与分析
    • 毛细管电泳市场
      • 概述
      • 毛细管电泳市场预测与分析
  • 蛋白质微阵列
    • 概述
    • 蛋白质微阵列市场预测与分析
    • 生物晶片市场
      • 概述
      • 生物晶片市场预测与分析
    • 微阵列仪器市场
      • 概述
      • 微阵列仪器市场预测与分析
  • X射线晶体学
    • 概述
    • X射线晶体学市场预测与分析
  • 表面等离激元共振
    • 概述
    • 表面等离子共振市场预测与分析
  • 蛋白质分级分离
    • 概述
    • 蛋白质分离市场预测与分析
  • 其他乐器
    • 概述
    • 其他仪器市场预测与分析

第 8 章:蛋白质体学市场 - 收入和 2028 年预测 - 试剂

  • 概述
  • 试剂市场预测与分析
  • 免疫检测试剂
    • 概述
    • 免疫分析试剂市场预测与分析
  • 光谱试剂
    • 概述
    • 光谱试剂市场预测与分析
  • 色谱试剂
    • 概述
    • 色谱试剂市场预测与分析
  • 蛋白质微阵列试剂
    • 概述
    • 蛋白质微阵列试剂市场预测与分析
  • X 射线晶体学试剂
    • 概述
    • X射线晶体学试剂市场预测与分析
  • 电泳试剂
    • 概述
    • 电泳试剂市场预测与分析
  • 蛋白质分级试剂
    • 概述
    • 蛋白质分级试剂市场预测与分析

第 9 章:蛋白质体学市场 - 2028 年收入与预测 - 服务与软体

  • 概述
  • 服务与软体市场预测与分析
  • 服务
    • 概述
    • 服务市场预测与分析
    • 蛋白质鑑定服务市场
      • 概述
      • 蛋白质鑑定服务市场预测与分析
    • 定量蛋白质体学服务市场
      • 概述
      • 定量蛋白质体学服务市场预测与分析
    • 蛋白质纯化服务市场
      • 概述
      • 蛋白质纯化服务市场预测与分析
    • 蛋白质分离服务市场
      • 概述
      • 蛋白质分离服务市场预测与分析
    • 蛋白质定序服务市场
      • 概述
      • 蛋白质定序服务市场预测与分析
    • 其他服务市场
      • 概述
      • 其他服务市场预测与分析
  • 软体
    • 概述
    • 软体市场预测与分析
    • 生物资讯服务市场
      • 概述
      • 生物资讯服务市场预测与分析
    • 生物资讯工具市场
      • 概述
      • 生物资讯工具市场预测与分析
    • 生物资讯资料库市场
      • 概述
      • 生物资讯资料库市场预测与分析

第 10 章:蛋白质体学市场 - 2028 年收入与预测 - 应用

  • 概述
  • 应用市场预测与分析
  • 临床诊断
    • 概述
    • 临床诊断市场预测与分析
  • 药物发现
    • 概述
    • 药物发现市场预测与分析
  • 其他应用
    • 概述
    • 其他应用市场预测与分析

第 11 章:蛋白质体学市场收入和 2028 年预测 - 地理分析

  • 北美洲
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 欧洲
      • 德国
      • 法国
      • 义大利
      • 西班牙
      • 英国
      • 欧洲其他地区
  • 亚太
    • 亚太
      • 澳洲
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 中东和非洲
      • 南非
      • 沙乌地阿拉伯
      • 阿联酋
      • 中东和非洲其他地区
  • 南美洲和中美洲
    • 南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区

第 12 章:COVID-19 大流行对全球蛋白质体市场的影响

  • 北美洲
  • 欧洲
  • 亚太
  • 中东和非洲
  • 南美洲和中美洲

第 13 章:产业格局

  • 併购
  • 协议、合作和合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 14 章:蛋白质体学市场,主要公司概况

  • THERMO FISHER SCIENTIFIC INC.
  • BIO-RAD LABORATORIES, INC.
  • AGILENT TECHNOLOGIES
  • DANAHER
  • PERKINELMER INC.
  • MERCK KGAA
  • LUMINEX CORPORATION
  • GENERAL ELECTRIC COMPANY
简介目录
Product Code: TIPHE100001115

According to our new research study on "Proteomics Market Forecast to 2030 - COVID-19 Impact and Global Analysis - by Product & Service, Application, and End User," the market is anticipated to grow from US$ 27.07 billion in 2022 and is projected to reach US$ 75.03 billion by 2030; it is expected to register a CAGR of 13.6% during 2022-2030. Market growth is attributed to the proliferating cases of chronic diseases and the growing prominence of nano proteomics. Growing technological advancements and R&D expenditure will likely provide growth opportunities for the proteomics market. However, the high costs of instruments and the dearth of skilled personnel hinder the growth of the proteomics market.

Proteomics, the detailed analysis of proteins, has become a significant field to study drug development, therapy, prognosis, and disease characterization. Proteomics technologies help with both infectious and noninfectious disease detection and therapy. The current proteomic methodologies are being made more reliable, biocompatible, specific, and reproducible through the use of nanotechnology as a technological platform. The shortcomings of conventional proteomic techniques are greatly assessed with the use of nanomaterials to enhance the quality of proteomic techniques by protein manipulation. In the pharmaceutical field, proteomics studies drug effects or the mechanism of toxicity. They are also widely used to identify and confirm the effectiveness of biomarkers.

North America accounted for a major share of the global proteomics market in 2022. The North American proteomics market is segmented into the US, Canada, and Mexico. The key factors driving the market growth in this region is the increasing investments in the development of structure-based drug design, demand for high-quality research tools for data reproducibility, growth in omics research, etc. Attention is being paid to the development of tailor-made treatments. Partnerships and collaborations between major regional companies also contribute to the market expansion in the region. For example, Thermo Fisher Scientific Inc. and Symphogen have collaborated to develop verified platform processes for optimized characterization and quality monitoring of complex therapeutic proteins. Also, proteomics research is at its peak in countries like the US.

Growing Technological Advancements and R&D Expenditure to Provide Market Opportunities in the Future

Manufacturers in the proteomics industry are focused on providing new methods and devices for disease diagnosis. Companies such as Agilent Technologies, Inc. have recognized the advantages of using technology out-licensing strategies to focus on developing products for protein analysis. The absolute quantification of protein-based diagnostics was made possible through the use of proteomics technology. Key proteomic services and other technologies, including microarray, X-ray crystallography, spectroscopic techniques, chromatography, electrophoresis, and surface plasma resonance systems, form the foundation of the proteomics market.

The increasing investments in research and development in proteomics are fostering market growth. The US National Institutes of Health (NIH) gave US$ 37 billion for biomedical research. This funding will aid in studying the fundamental mechanisms of disease development, identifying biomarkers that indicate the presence of a disease, or identifying the gene or protein that causes the disease. The Novo Nordisk Foundation granted the University of Copenhagen a grant of up to US$ 1.5 million to build a mass spectrometry facility, an important step toward protein research. The market quickly gained momentum after the outbreak of COVID-19.

Key players are crucial in improving people's access to quality healthcare and medicines in developing countries, which also expands their economic prospects, and they are also working to increase economic opportunities by creating more jobs, making significant investments, influencing public policy, and providing trainings. The pharmaceutical industry has a significant impact on the growth of economic opportunities in developing countries. In recent years, pharmaceutical companies have achieved excellent financial results. For example, Thermo Fisher Scientific, Inc. posted record profits last year, and future performance is predicted to be even better. The market will continue to flourish as several biopharmaceutical companies are emerging as key players and various R&D activities are being conducted, thereby providing growth opportunities for the global market.

Product & Service -Based Insights

Based on product & service, the proteomics market is divided into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment held the largest market share in 2022 and is likely to register the highest CAGR of 14.1% during 2022-2030.

Reagents & kits, consumables, and strips are increasingly used for studying various biological materials in research universities, research institutions, and other areas. Government initiatives in the field of proteomics and genomics are propelling research activities in disease diagnostics. Technical advancements in advanced instruments, such as 3D electrophoresis protein analyzers, which increase biological research's speed, efficiency, and productivity, are also propelling the demand for reagents and consumables. These factors are contributing to the growing proteomics market size for the segment.

Application -Based Insights

The market, based on application, is divided into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest proteomics market share in 2022. However, the drug discovery & development segment is expected to register the highest CAGR of 14.4% during 2022-2030.

End User -Based Insights

Based on end user, the market is segmented into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, others. The pharmaceutical & biotechnology companies segment held the largest proteomics market share in 2022. However, the research & clinical laboratories segment is estimated to register the highest CAGR of 14.5% during 2022-2030.

Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquisition of a new customer base for tapping prevailing business opportunities.

In January 2022, Seer, Inc. announced the debut of the Centers of Excellence program and the commercial release of the Proteograph Product Suite. The Proteograph Product Suite provides unbiased, unmatched access to the proteome. The approach uses uniquely designed nanoparticles to produce a breakthrough product that enables rapid, thorough, and unbiased large-scale proteomics.

In February 2021, Agilent Technologies Inc. launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit, designed for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.

In February 2021, Poochon Scientific, LLC acquired a new Thermo Orbitrap Exploris 240 mass spectrometer that has BioPharma option and FAIMS Pro interface. It is a versatile, new-generation, high-resolution mass spectrometer that offers exceptional performance for proteomics, metabolomics, and biopharmaceutical characterization.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the proteomics market report.

Table Of Contents

1. INTRODUCTION

  • 1.1. SCOPE OF THE STUDY
  • 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
  • 1.3. MARKET SEGMENTATION
    • 1.3.1 Proteomics Market - By Instrument
    • 1.3.2 Proteomics Market - By Reagents
    • 1.3.3 Proteomics Market - By Services and Software
    • 1.3.4 Proteomics Market - By Application
    • 1.3.5 Proteomics Market - By Region
      • 1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PROTEOMICS MARKET LANDSCAPE

  • 4.1. OVERVIEW
  • 4.2. PEST ANALYSIS
    • 4.2.1 North America - Pest Analysis
    • 4.2.2 Europe - Pest Analysis
    • 4.2.3 Asia-Pacific - Pest Analysis
    • 4.2.4 Middle East and Africa - Pest Analysis
    • 4.2.5 South and Central America - Pest Analysis
  • 4.3. EXPERT OPINIONS

5. PROTEOMICS MARKET - KEY MARKET DYNAMICS

  • 5.1. KEY MARKET DRIVERS
  • 5.2. KEY MARKET RESTRAINTS
  • 5.3. KEY MARKET OPPORTUNITIES
  • 5.4. FUTURE TRENDS
  • 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROTEOMICS MARKET - GLOBAL MARKET ANALYSIS

  • 6.1. PROTEOMICS - GLOBAL MARKET OVERVIEW
  • 6.2. PROTEOMICS - GLOBAL MARKET AND FORECAST TO 2028
  • 6.3. MARKET POSITIONING

7. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - INSTRUMENT

  • 7.1. OVERVIEW
  • 7.2. INSTRUMENT MARKET FORECASTS AND ANALYSIS
  • 7.3. SPECTROSCOPY
    • 7.3.1. Overview
    • 7.3.2. Spectroscopy Market Forecast and Analysis
    • 7.3.3. Mass Spectroscopy Market
      • 7.3.3.1. Overview
      • 7.3.3.2. Mass Spectroscopy Market Forecast and Analysis
    • 7.3.4. NMR Spectroscopy Market
      • 7.3.4.1. Overview
      • 7.3.4.2. NMR Spectroscopy Market Forecast and Analysis
    • 7.3.5. Circular Dichroism (CD) Spectroscopy Market
      • 7.3.5.1. Overview
      • 7.3.5.2. Circular Dichroism (CD) Spectroscopy Market Forecast and Analysis
  • 7.4. CHROMATOGRAPHY
    • 7.4.1. Overview
    • 7.4.2. Chromatography Market Forecast and Analysis
    • 7.4.3. HPLC Market
      • 7.4.3.1. Overview
      • 7.4.3.2. HPLC Market Forecast and Analysis
    • 7.4.4. Ion Chromatography Market
      • 7.4.4.1. Overview
      • 7.4.4.2. Ion Chromatography Market Forecast and Analysis
    • 7.4.5. Ion Chromatography Market
      • 7.4.5.1. Overview
      • 7.4.5.2. Ion Chromatography Market Forecast and Analysis
    • 7.4.6. Supercritical Fluid Chromatography Market
      • 7.4.6.1. Overview
      • 7.4.6.2. Supercritical Fluid Chromatography Market Forecast and Analysis
  • 7.5. ELECTROPHORESIS
    • 7.5.1. Overview
    • 7.5.2. Electrophoresis Market Forecast and Analysis
    • 7.5.3. Gel Electrophoresis Market
      • 7.5.3.1. Overview
      • 7.5.3.2. Gel Electrophoresis Market Forecast and Analysis
    • 7.5.4. Capillary Electrophoresis Market
      • 7.5.4.1. Overview
      • 7.5.4.2. Capillary Electrophoresis Market Forecast and Analysis
  • 7.6. PROTEIN MICROARRAYS
    • 7.6.1. Overview
    • 7.6.2. Protein Microarrays Market Forecast and Analysis
    • 7.6.3. Biochips Market
      • 7.6.3.1. Overview
      • 7.6.3.2. Biochips Market Forecast and Analysis
    • 7.6.4. Microarray Instruments Market
      • 7.6.4.1. Overview
      • 7.6.4.2. Microarray Instruments Market Forecast and Analysis
  • 7.7. X-RAY CRYSTALLOGRAPHY
    • 7.7.1. Overview
    • 7.7.2. X-Ray Crystallography Market Forecast and Analysis
  • 7.8. SURFACE PLASMON RESONANCE
    • 7.8.1. Overview
    • 7.8.2. Surface Plasmon Resonance Market Forecast and Analysis
  • 7.9. PROTEIN FRACTIONATION
    • 7.9.1. Overview
    • 7.9.2. Protein Fractionation Market Forecast and Analysis
  • 7.10. OTHER INSTRUMENT
    • 7.10.1. Overview
    • 7.10.2. Other Instrument Market Forecast and Analysis

8. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - REAGENTS

  • 8.1. OVERVIEW
  • 8.2. REAGENTS MARKET FORECASTS AND ANALYSIS
  • 8.3. IMMUNOASSAY REAGENTS
    • 8.3.1. Overview
    • 8.3.2. Immunoassay Reagents Market Forecast and Analysis
  • 8.4. SPECTROSCOPY REAGENTS
    • 8.4.1. Overview
    • 8.4.2. Spectroscopy Reagents Market Forecast and Analysis
  • 8.5. CHROMATOGRAPHY REAGENTS
    • 8.5.1. Overview
    • 8.5.2. Chromatography Reagents Market Forecast and Analysis
  • 8.6. PROTEIN MICROARRAY REAGENTS
    • 8.6.1. Overview
    • 8.6.2. Protein Microarray Reagents Market Forecast and Analysis
  • 8.7. X-RAY CRYSTALLOGRAPHY REAGENTS
    • 8.7.1. Overview
    • 8.7.2. X-Ray Crystallography Reagents Market Forecast and Analysis
  • 8.8. ELECTROPHORESIS REAGENTS
    • 8.8.1. Overview
    • 8.8.2. Electrophoresis Reagents Market Forecast and Analysis
  • 8.9. PROTEIN FRACTIONATION REAGENTS
    • 8.9.1. Overview
    • 8.9.2. Protein Fractionation Reagents Market Forecast and Analysis

9. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - SERVICES AND SOFTWARE

  • 9.1. OVERVIEW
  • 9.2. SERVICES AND SOFTWARE MARKET FORECASTS AND ANALYSIS
  • 9.3. SERVICES
    • 9.3.1. Overview
    • 9.3.2. Services Market Forecast and Analysis
    • 9.3.3. Protein Identification Services Market
      • 9.3.3.1. Overview
      • 9.3.3.2. Protein Identification Services Market Forecast and Analysis
    • 9.3.4. Quantitative Proteomics Services Market
      • 9.3.4.1. Overview
      • 9.3.4.2. Quantitative Proteomics Services Market Forecast and Analysis
    • 9.3.5. Protein Purification Services Market
      • 9.3.5.1. Overview
      • 9.3.5.2. Protein Purification Services Market Forecast and Analysis
    • 9.3.6. Protein Separation Services Market
      • 9.3.6.1. Overview
      • 9.3.6.2. Protein Separation Services Market Forecast and Analysis
    • 9.3.7. Protein Sequencing Services Market
      • 9.3.7.1. Overview
      • 9.3.7.2. Protein Sequencing Services Market Forecast and Analysis
    • 9.3.8. Others Services Market
      • 9.3.8.1. Overview
      • 9.3.8.2. Others Services Market Forecast and Analysis
  • 9.4. SOFTWARE
    • 9.4.1. Overview
    • 9.4.2. Software Market Forecast and Analysis
    • 9.4.3. Bioinformatics Services Market
      • 9.4.3.1. Overview
      • 9.4.3.2. Bioinformatics Services Market Forecast and Analysis
    • 9.4.4. Bioinformatics Tools Market
      • 9.4.4.1. Overview
      • 9.4.4.2. Bioinformatics Tools Market Forecast and Analysis
    • 9.4.5. Bioinformatics Databases Market
      • 9.4.5.1. Overview
      • 9.4.5.2. Bioinformatics Databases Market Forecast and Analysis

10. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION

  • 10.1. OVERVIEW
  • 10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
  • 10.3. CLINICAL DIAGNOSTICS
    • 10.3.1. Overview
    • 10.3.2. Clinical Diagnostics Market Forecast and Analysis
  • 10.4. DRUG DISCOVERY
    • 10.4.1. Overview
    • 10.4.2. Drug Discovery Market Forecast and Analysis
  • 10.5. OTHER APPLICATIONS
    • 10.5.1. Overview
    • 10.5.2. Other Applications Market Forecast and Analysis

11. PROTEOMICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1 North America Proteomics Market Overview
    • 11.1.2 North America Proteomics Market Forecasts and Analysis
    • 11.1.3 North America Proteomics Market Forecasts and Analysis - By Instrument
    • 11.1.4 North America Proteomics Market Forecasts and Analysis - By Reagents
    • 11.1.5 North America Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.1.6 North America Proteomics Market Forecasts and Analysis - By Application
    • 11.1.7 North America Proteomics Market Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Proteomics Market
        • 11.1.7.1.1 United States Proteomics Market by Instrument
        • 11.1.7.1.2 United States Proteomics Market by Reagents
        • 11.1.7.1.3 United States Proteomics Market by Services and Software
        • 11.1.7.1.4 United States Proteomics Market by Application
      • 11.1.7.2 Canada Proteomics Market
        • 11.1.7.2.1 Canada Proteomics Market by Instrument
        • 11.1.7.2.2 Canada Proteomics Market by Reagents
        • 11.1.7.2.3 Canada Proteomics Market by Services and Software
        • 11.1.7.2.4 Canada Proteomics Market by Application
      • 11.1.7.3 Mexico Proteomics Market
        • 11.1.7.3.1 Mexico Proteomics Market by Instrument
        • 11.1.7.3.2 Mexico Proteomics Market by Reagents
        • 11.1.7.3.3 Mexico Proteomics Market by Services and Software
        • 11.1.7.3.4 Mexico Proteomics Market by Application
  • 11.2. EUROPE
    • 11.2.1 Europe Proteomics Market Overview
    • 11.2.2 Europe Proteomics Market Forecasts and Analysis
    • 11.2.3 Europe Proteomics Market Forecasts and Analysis - By Instrument
    • 11.2.4 Europe Proteomics Market Forecasts and Analysis - By Reagents
    • 11.2.5 Europe Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.2.6 Europe Proteomics Market Forecasts and Analysis - By Application
    • 11.2.7 Europe Proteomics Market Forecasts and Analysis - By Countries
      • 11.2.7.1 Germany Proteomics Market
        • 11.2.7.1.1 Germany Proteomics Market by Instrument
        • 11.2.7.1.2 Germany Proteomics Market by Reagents
        • 11.2.7.1.3 Germany Proteomics Market by Services and Software
        • 11.2.7.1.4 Germany Proteomics Market by Application
      • 11.2.7.2 France Proteomics Market
        • 11.2.7.2.1 France Proteomics Market by Instrument
        • 11.2.7.2.2 France Proteomics Market by Reagents
        • 11.2.7.2.3 France Proteomics Market by Services and Software
        • 11.2.7.2.4 France Proteomics Market by Application
      • 11.2.7.3 Italy Proteomics Market
        • 11.2.7.3.1 Italy Proteomics Market by Instrument
        • 11.2.7.3.2 Italy Proteomics Market by Reagents
        • 11.2.7.3.3 Italy Proteomics Market by Services and Software
        • 11.2.7.3.4 Italy Proteomics Market by Application
      • 11.2.7.4 Spain Proteomics Market
        • 11.2.7.4.1 Spain Proteomics Market by Instrument
        • 11.2.7.4.2 Spain Proteomics Market by Reagents
        • 11.2.7.4.3 Spain Proteomics Market by Services and Software
        • 11.2.7.4.4 Spain Proteomics Market by Application
      • 11.2.7.5 United Kingdom Proteomics Market
        • 11.2.7.5.1 United Kingdom Proteomics Market by Instrument
        • 11.2.7.5.2 United Kingdom Proteomics Market by Reagents
        • 11.2.7.5.3 United Kingdom Proteomics Market by Services and Software
        • 11.2.7.5.4 United Kingdom Proteomics Market by Application
      • 11.2.7.6 Rest of Europe Proteomics Market
        • 11.2.7.6.1 Rest of Europe Proteomics Market by Instrument
        • 11.2.7.6.2 Rest of Europe Proteomics Market by Reagents
        • 11.2.7.6.3 Rest of Europe Proteomics Market by Services and Software
        • 11.2.7.6.4 Rest of Europe Proteomics Market by Application
  • 11.3. ASIA-PACIFIC
    • 11.3.1 Asia-Pacific Proteomics Market Overview
    • 11.3.2 Asia-Pacific Proteomics Market Forecasts and Analysis
    • 11.3.3 Asia-Pacific Proteomics Market Forecasts and Analysis - By Instrument
    • 11.3.4 Asia-Pacific Proteomics Market Forecasts and Analysis - By Reagents
    • 11.3.5 Asia-Pacific Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.3.6 Asia-Pacific Proteomics Market Forecasts and Analysis - By Application
    • 11.3.7 Asia-Pacific Proteomics Market Forecasts and Analysis - By Countries
      • 11.3.7.1 Australia Proteomics Market
        • 11.3.7.1.1 Australia Proteomics Market by Instrument
        • 11.3.7.1.2 Australia Proteomics Market by Reagents
        • 11.3.7.1.3 Australia Proteomics Market by Services and Software
        • 11.3.7.1.4 Australia Proteomics Market by Application
      • 11.3.7.2 China Proteomics Market
        • 11.3.7.2.1 China Proteomics Market by Instrument
        • 11.3.7.2.2 China Proteomics Market by Reagents
        • 11.3.7.2.3 China Proteomics Market by Services and Software
        • 11.3.7.2.4 China Proteomics Market by Application
      • 11.3.7.3 India Proteomics Market
        • 11.3.7.3.1 India Proteomics Market by Instrument
        • 11.3.7.3.2 India Proteomics Market by Reagents
        • 11.3.7.3.3 India Proteomics Market by Services and Software
        • 11.3.7.3.4 India Proteomics Market by Application
      • 11.3.7.4 Japan Proteomics Market
        • 11.3.7.4.1 Japan Proteomics Market by Instrument
        • 11.3.7.4.2 Japan Proteomics Market by Reagents
        • 11.3.7.4.3 Japan Proteomics Market by Services and Software
        • 11.3.7.4.4 Japan Proteomics Market by Application
      • 11.3.7.5 South Korea Proteomics Market
        • 11.3.7.5.1 South Korea Proteomics Market by Instrument
        • 11.3.7.5.2 South Korea Proteomics Market by Reagents
        • 11.3.7.5.3 South Korea Proteomics Market by Services and Software
        • 11.3.7.5.4 South Korea Proteomics Market by Application
      • 11.3.7.6 Rest of Asia-Pacific Proteomics Market
        • 11.3.7.6.1 Rest of Asia-Pacific Proteomics Market by Instrument
        • 11.3.7.6.2 Rest of Asia-Pacific Proteomics Market by Reagents
        • 11.3.7.6.3 Rest of Asia-Pacific Proteomics Market by Services and Software
        • 11.3.7.6.4 Rest of Asia-Pacific Proteomics Market by Application
  • 11.4. MIDDLE EAST AND AFRICA
    • 11.4.1 Middle East and Africa Proteomics Market Overview
    • 11.4.2 Middle East and Africa Proteomics Market Forecasts and Analysis
    • 11.4.3 Middle East and Africa Proteomics Market Forecasts and Analysis - By Instrument
    • 11.4.4 Middle East and Africa Proteomics Market Forecasts and Analysis - By Reagents
    • 11.4.5 Middle East and Africa Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.4.6 Middle East and Africa Proteomics Market Forecasts and Analysis - By Application
    • 11.4.7 Middle East and Africa Proteomics Market Forecasts and Analysis - By Countries
      • 11.4.7.1 South Africa Proteomics Market
        • 11.4.7.1.1 South Africa Proteomics Market by Instrument
        • 11.4.7.1.2 South Africa Proteomics Market by Reagents
        • 11.4.7.1.3 South Africa Proteomics Market by Services and Software
        • 11.4.7.1.4 South Africa Proteomics Market by Application
      • 11.4.7.2 Saudi Arabia Proteomics Market
        • 11.4.7.2.1 Saudi Arabia Proteomics Market by Instrument
        • 11.4.7.2.2 Saudi Arabia Proteomics Market by Reagents
        • 11.4.7.2.3 Saudi Arabia Proteomics Market by Services and Software
        • 11.4.7.2.4 Saudi Arabia Proteomics Market by Application
      • 11.4.7.3 U.A.E Proteomics Market
        • 11.4.7.3.1 U.A.E Proteomics Market by Instrument
        • 11.4.7.3.2 U.A.E Proteomics Market by Reagents
        • 11.4.7.3.3 U.A.E Proteomics Market by Services and Software
        • 11.4.7.3.4 U.A.E Proteomics Market by Application
      • 11.4.7.4 Rest of Middle East and Africa Proteomics Market
        • 11.4.7.4.1 Rest of Middle East and Africa Proteomics Market by Instrument
        • 11.4.7.4.2 Rest of Middle East and Africa Proteomics Market by Reagents
        • 11.4.7.4.3 Rest of Middle East and Africa Proteomics Market by Services and Software
        • 11.4.7.4.4 Rest of Middle East and Africa Proteomics Market by Application
  • 11.5. SOUTH AND CENTRAL AMERICA
    • 11.5.1 South and Central America Proteomics Market Overview
    • 11.5.2 South and Central America Proteomics Market Forecasts and Analysis
    • 11.5.3 South and Central America Proteomics Market Forecasts and Analysis - By Instrument
    • 11.5.4 South and Central America Proteomics Market Forecasts and Analysis - By Reagents
    • 11.5.5 South and Central America Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.5.6 South and Central America Proteomics Market Forecasts and Analysis - By Application
    • 11.5.7 South and Central America Proteomics Market Forecasts and Analysis - By Countries
      • 11.5.7.1 Brazil Proteomics Market
        • 11.5.7.1.1 Brazil Proteomics Market by Instrument
        • 11.5.7.1.2 Brazil Proteomics Market by Reagents
        • 11.5.7.1.3 Brazil Proteomics Market by Services and Software
        • 11.5.7.1.4 Brazil Proteomics Market by Application
      • 11.5.7.2 Argentina Proteomics Market
        • 11.5.7.2.1 Argentina Proteomics Market by Instrument
        • 11.5.7.2.2 Argentina Proteomics Market by Reagents
        • 11.5.7.2.3 Argentina Proteomics Market by Services and Software
        • 11.5.7.2.4 Argentina Proteomics Market by Application
      • 11.5.7.3 Rest of South and Central America Proteomics Market
        • 11.5.7.3.1 Rest of South and Central America Proteomics Market by Instrument
        • 11.5.7.3.2 Rest of South and Central America Proteomics Market by Reagents
        • 11.5.7.3.3 Rest of South and Central America Proteomics Market by Services and Software
        • 11.5.7.3.4 Rest of South and Central America Proteomics Market by Application

12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROTEOMICS MARKET

  • 12.1 North America
  • 12.2 Europe
  • 12.3 Asia-Pacific
  • 12.4 Middle East and Africa
  • 12.5 South and Central America

13. INDUSTRY LANDSCAPE

  • 13.1. MERGERS AND ACQUISITIONS
  • 13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
  • 13.3. NEW PRODUCT LAUNCHES
  • 13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. PROTEOMICS MARKET, KEY COMPANY PROFILES

  • 14.1. THERMO FISHER SCIENTIFIC INC.
    • 14.1.1. Key Facts
    • 14.1.2. Business Description
    • 14.1.3. Products and Services
    • 14.1.4. Financial Overview
    • 14.1.5. SWOT Analysis
    • 14.1.6. Key Developments
  • 14.2. BIO-RAD LABORATORIES, INC.
    • 14.2.1. Key Facts
    • 14.2.2. Business Description
    • 14.2.3. Products and Services
    • 14.2.4. Financial Overview
    • 14.2.5. SWOT Analysis
    • 14.2.6. Key Developments
  • 14.3. AGILENT TECHNOLOGIES
    • 14.3.1. Key Facts
    • 14.3.2. Business Description
    • 14.3.3. Products and Services
    • 14.3.4. Financial Overview
    • 14.3.5. SWOT Analysis
    • 14.3.6. Key Developments
  • 14.4. DANAHER
    • 14.4.1. Key Facts
    • 14.4.2. Business Description
    • 14.4.3. Products and Services
    • 14.4.4. Financial Overview
    • 14.4.5. SWOT Analysis
    • 14.4.6. Key Developments
  • 14.5. PERKINELMER INC.
    • 14.5.1. Key Facts
    • 14.5.2. Business Description
    • 14.5.3. Products and Services
    • 14.5.4. Financial Overview
    • 14.5.5. SWOT Analysis
    • 14.5.6. Key Developments
  • 14.6. MERCK KGAA
    • 14.6.1. Key Facts
    • 14.6.2. Business Description
    • 14.6.3. Products and Services
    • 14.6.4. Financial Overview
    • 14.6.5. SWOT Analysis
    • 14.6.6. Key Developments
  • 14.7. LUMINEX CORPORATION
    • 14.7.1. Key Facts
    • 14.7.2. Business Description
    • 14.7.3. Products and Services
    • 14.7.4. Financial Overview
    • 14.7.5. SWOT Analysis
    • 14.7.6. Key Developments
  • 14.8. GENERAL ELECTRIC COMPANY
    • 14.8.1. Key Facts
    • 14.8.2. Business Description
    • 14.8.3. Products and S